TY - JOUR
T1 - Stereoselective covalent binding of anti-benzo(A)pyrene diol epoxide to dna conformation of enantiomer adducts
AU - Geacintov, Nicholas E.
AU - Ibanez, Victor
AU - Gagliano, Antoine G.
AU - Jacobs, Stephen A.
AU - Harvey, Ronald G.
N1 - Funding Information:
We thank Dr. Y. Mnyukh for performing the linear dichroism measurements. This research was supported by the U.S. Public Health Service, Grant No. CA20851 awarded by the National Cancer Institute, Department of Health and Human Services, and in part by the Department of Energy (Contract DE-AC02-78EV04959 to N.E.G., and Contract No. E(ll-1)2366 at the Radiation and Solid State Laboratory). The preparation of the enantiomers of anti-BaPDE at the University of Chicago was supported by an American Cancer Society Grant (BC-132), and by the U.S. Public Health Service, Grants No. CA09183 and CA14599 awarded by the National Cancer Institute, Department of Health and Human Services.
PY - 1984/6
Y1 - 1984/6
N2 - The conformation of adducts derived from the reactions and covalent binding of the (+) and (-) enantiomers of 7/3, 8a-dihydroxy-9a, 10a-epoxy-7, 8,9, 10-tetrahydrobenzo(a)pyrene (anti- BaPDE) with double-stranded calf thymus DNA in vitro were investigated utilizing the electric linear dichroism technique. The linear dichroism and absorption spectra of the covalent DNA complexes are interpreted in terms of a superposition of two types of binding sites. One of these conformations (site I) is a complex in which the plane of the pyrene residue is close to parallel (within 30°) to the planes of the DNA bases (quasi-intercalation), while the other (site II) is an external binding site; this latter type of adduct is attributed to the covalent binding of an/j-BaPDE to the exocyclic amino group of deoxyguanine (N2-dG), while site I adducts are attributed to the 06-deoxyguanine and N6-deoxyadenine adducts identified in the product analysis of P. Brookes and M.R. Osborne (Carcinogenesis (1982) 3, 1223-1226). Site II adducts are dominant (~90% in the covalent complexes derived from the (+) enantiomer), but account for only 50±5% of the adducts in the case of the (-)-enantiomer. The orientation of site II complexes is different by 20±10° in the adducts derived from the binding of the (+) and the (-) enantiomers to DNA, the long axis of the pyrene chromo- phore being oriented more parallel to the axis of the DNA helix in the case of the (+) enantiomer. These findings support the proposals by Brookes and Osborne that the difference in spatial orientation of the N2-dG adducts of (-)-an<(-BaPDE together with their lower abundance may account for the lower biological activity of the (-) enantiomer. The external site II adducts, rather than site I adducts, appear to be correlated with the biological activity of these compounds.
AB - The conformation of adducts derived from the reactions and covalent binding of the (+) and (-) enantiomers of 7/3, 8a-dihydroxy-9a, 10a-epoxy-7, 8,9, 10-tetrahydrobenzo(a)pyrene (anti- BaPDE) with double-stranded calf thymus DNA in vitro were investigated utilizing the electric linear dichroism technique. The linear dichroism and absorption spectra of the covalent DNA complexes are interpreted in terms of a superposition of two types of binding sites. One of these conformations (site I) is a complex in which the plane of the pyrene residue is close to parallel (within 30°) to the planes of the DNA bases (quasi-intercalation), while the other (site II) is an external binding site; this latter type of adduct is attributed to the covalent binding of an/j-BaPDE to the exocyclic amino group of deoxyguanine (N2-dG), while site I adducts are attributed to the 06-deoxyguanine and N6-deoxyadenine adducts identified in the product analysis of P. Brookes and M.R. Osborne (Carcinogenesis (1982) 3, 1223-1226). Site II adducts are dominant (~90% in the covalent complexes derived from the (+) enantiomer), but account for only 50±5% of the adducts in the case of the (-)-enantiomer. The orientation of site II complexes is different by 20±10° in the adducts derived from the binding of the (+) and the (-) enantiomers to DNA, the long axis of the pyrene chromo- phore being oriented more parallel to the axis of the DNA helix in the case of the (+) enantiomer. These findings support the proposals by Brookes and Osborne that the difference in spatial orientation of the N2-dG adducts of (-)-an<(-BaPDE together with their lower abundance may account for the lower biological activity of the (-) enantiomer. The external site II adducts, rather than site I adducts, appear to be correlated with the biological activity of these compounds.
UR - http://www.scopus.com/inward/record.url?scp=0021436725&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021436725&partnerID=8YFLogxK
U2 - 10.1080/07391102.1984.10507531
DO - 10.1080/07391102.1984.10507531
M3 - Article
C2 - 6443875
AN - SCOPUS:0021436725
SN - 0739-1102
VL - 1
SP - 1473
EP - 1485
JO - Journal of Biomolecular Structure and Dynamics
JF - Journal of Biomolecular Structure and Dynamics
IS - 6
ER -